首页 | 本学科首页   官方微博 | 高级检索  
检索        


Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome
Authors:Vandana Shashi  Thomas R Kwapil  Jessica Kaczorowski  Margaret N Berry  Cesar S Santos  Timothy D Howard  Dhruman Goradia  Konasale Prasad  Diwadkar Vaibhav  Rajaprabhakaran Rajarethinam  Edward Spence  Matcheri S Keshavan
Institution:1. Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada;2. Department of Psychiatry, University of Toronto, Ontario, Canada;3. Clinical Genetics Service, Centre for Addiction and Mental Health, Toronto, Ontario, Canada;4. Division of Cardiology, Department of Medicine, University Health Network, Toronto, Ontario, Canada;5. Toronto Congenital Cardiac Centre for Adults, Toronto General Hospital, Toronto, Ontario, Canada;6. Dalglish Family Hearts and Minds Clinic for Adults with 22q11.2DS, Toronto General Hospital, Toronto, Ontario, Canada;7. Department of Psychiatry, University Health Network, Toronto, Ontario, Canada;1. Harvard Medical School, Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Boston, MA 02115, United States;2. Harvard Medical School, Department of Psychiatry at Massachusetts General Hospital, Boston, MA 02114, United States;3. Martinos Center for Biomedical Imaging, Massachusetts Institute of Technology, Harvard Medical School and Massachusetts General Hospital, Charlestown, MA 02129, United States;4. Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA 02115, United States;5. Harvard Medical School Department of Psychiatry at McLean Hospital, Belmont, MA 02478, United States;6. Harvard Medical School Departments of Neurology and Radiology Services, Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA 02129, United States;7. Massachusetts Institute of Technology, Department of Brain and Cognitive Sciences, Harvard-MIT Division of Health Sciences and Technology, Poitras Center for Affective Disorders Research, Cambridge, MA 02139, United States;8. SUNY Genetics Research Program, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY 13210, United States;9. University of California, San Diego, Department of Psychiatry, Institute of Behavior Genomics, La Jolla, CA 92093, United States
Abstract:Chromosome 22q11.2 deletion syndrome (22q11DS) is associated with cognitive deficits and morphometric brain abnormalities in childhood and a markedly elevated risk of schizophrenia in adolescence/early adulthood. Determining the relationship between neurocognition and neuroimaging findings would yield crucial information about childhood neurodevelopment and provide a basis for the study of the trajectory that occurs on the pathway to psychosis. We compared morphometric brain findings between non-psychotic children with 22q11DS (n = 22) and healthy controls (n = 16), and examined the association between neurocognitive functioning and morphometric brain findings. Volumetric regional gray matter differences between the 22q11DS and control subjects were measured, and correlations of the regional gray matter volumes and neurocognition were performed. Children with 22q11DS demonstrated reductions in gray matter in several brain regions, chiefly the frontal cortices, the cingulate gyrus and the cerebellum. The volumetric reductions in these salient areas were associated with poor performance in sustained attention, executive function and verbal memory; however, the relation of brain volume with cognitive performance did not differ between the patient and control groups. Thus, children with 22q11DS demonstrate gray matter reductions in multiple brain regions that are thought to be relevant to schizophrenia. The correlation of these volumetric reductions with poor neurocognition indicates that these brain regions may mediate higher neurocognitive functions implicated in schizophrenia.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号